Spirometry and exhaled nitric oxide are two important complimentary tools to identify and assess asthma control in children. We aimed to determine the ability of a new suggested spirometry-adjusted fraction of exhaled nitric oxide (NO) index in doing that. A random sample of 1602 schoolchildren were screened by a health questionnaire, skin prick tests, spirometry with bronchodilation and exhaled NO. A total of 662 children were included with median (IQR) exhaled NO 11(14) ppb. Receiver operating characteristic (ROC) curves using exhaled NO equations from Malmberg, Kovesi and Buchvald, and spirometry-adjusted fraction of exhaled NO values were applied to identify asthmatic children and uncontrolled asthma. Receiver operating characteristic (ROC) curves failed to identify asthmatic children (all AUC < 0.700). Spirometryadjusted fraction of exhaled NO/FEV 1 (AUC = 0.712; P = .010) and NO/FEF 25%-75% (AUC = 0.735 P = .004) had a fair and increased ability to identify uncontrolled disease compared with exhaled NO (AUC = 0.707; P = .011) or the Malmberg equation (AUC = 0.701; P = .014). Sensitivity and specificity identifying non-controlled asthma were 59% and 81%, respectively, for the cut-off value of 9.7 ppb/L for exhaled NO/FEV 1 , and 40% and 100% for 15.7 ppb/L/s for exhaled NO/FEF 25%-75% . Exhaled NO did not allow to identify childhood asthma. Spirometry-adjusted fraction of exhaled NO performed better-assessing asthma control in children. Thus, although more validation studies are needed, we suggest its use in epidemiological studies to assess asthma control.
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Although the diagnostic accuracy of exhaled NO in the identification of asthma in children is moderate, it suggests that it might be a promising tool 6 and the confounding or effect modification of atopy is believed to be a key feature that limits the usefulness of exhaled NO in asthma diagnosis.
Exhaled nitric oxide has shown to be efficient in guiding medication management, as a reduction of 20% in exhaled NO is considered indicative of a response to anti-inflammatory therapy. 3 However, no significant advantage was seen with the specific use of exhaled NO-driven protocols to guide asthma treatment compared with other methods, 7, 8 and according to GINA guidelines, 9 treatment of asthmatic children usually relies on symptoms reported by the child and/or guardians. Furthermore, correlations between airway inflammation and symptoms, asthma control and asthma severity are weak or absent. 1, [9] [10] [11] In steroid-naïve patients, high exhaled NO levels predict a good response to inhaled corticosteroids (ICS) treatment, and a low level of exhaled NO in adults in ICS treatment is associated with reduced likelihood ratio of exacerbation. 12 Until now, it is not possible to provide clear recommendations for the utility of the exhaled NO in asthma management, as studies failed to show an overall benefit in the rate of exacerbations as well as in asthma control, lung function and use of oral corticosteroids during exacerbations. 13 In a recent study, exhaled NO was used in relation to FEV 1 (exhaled NO/FEV 1 ) to distinguish patients with asthma from those without with promising results. 14 This kind of approach could be a way to minimize the influence of baseline bronchial constriction on exhaled NO.
With this study, we aimed to assess the ability of spirometryadjusted fraction of exhaled nitric oxide to identify and assess asthma control in children, in comparison with traditional approaches.
| METHODS
| Study design
This study is a cross-sectional analysis of data of 1602 children, aged between 8 and 12 years. Assessments were carried out between January and May of 2014 and 2015 (Data S1). The questionnaire included previous and current respiratory symptoms, questions about congenital anomalies, systemic diseases, long-term medication and environmental exposure.
| Assessments
All the participants completed anthropometric measurements. Skin prick tests were performed on the forearm using a QuickTestTM applicator containing house dust mite, mix of weeds, mix of grasses, cat dander, dog dander and Alternaria alternata, negative and a positive controls (Hall Allergy, Netherlands). Exhaled NO was analysed using a NOBreath® (Bedfont® Scientific Ltd, Maidstone, UK).
Spirometry was carried out using Spirolab spirometer (MIR, Italy) and the WINSPIROPRO® software. Reversibility testing was performed using four separate doses of 100 μg salbutamol through a space chamber-coupled MDI. A detailed description of assessment methods is presented in the online repository.
| Definitions and participants
Current asthma was defined as symptomatic children (wheezing in the last 12 months, or wheezing with exercise, or waking at night with wheezing in the last months, or coughing at night in the last 12 months or coughing more than 3 months in the last year) with reported medical diagnosis or evidence of airway reversibility. 15 Uncontrolled asthma was defined as an increase of at least 12% of the forced expiratory volume in 1-second (FEV1) after bronchodilation test or respiratory symptoms in the previous weeks with exhaled NO levels higher than 35 ppb. 16 The control group was composed by all included participants who do not meet the asthma group inclusion criteria. Armonk, NY, USA: IBM Corp.) was used for data analysis and for drawing graphs. All statistical data with P < .05 were considered significant.
| Statistical analysis
| Ethics statement
Data collection was approved by the University Ethics Committee, and a written informed consent was obtained from each participant caregiver.
| RESULTS
Exclusion criteria were inability to correctly perform spirometry or exhaled NO manoeuvres, incomplete responses to the questionnaire, refuse to perform skin prick tests by children or guardians.
A total of 662 children were enrolled (Data S1), 74 (11.2%) were included in the asthma group, and a positive bronchodilation test was found in 52 (8.0%). Atopic children represented about a third (35.3%) of the included participants and presented significantly higher exhaled NO levels when compared to non-atopic ( Table 1 ).
The accuracy of absolute values of exhaled NO (AUC = 0.620, P = .001), as well as of the Malmberg (AUC = 0.620, P = .001) and
Kovesi (AUC = 0.621, P = .001) predicted values, was poor to identify asthmatic children (Fig. S2 ). Using the low, normal or high score values, according to Buchvald classification, exhaled NO failed to do it with an even lower AUC (AUC = 0.595, P = .008). In non-atopic children, the diagnostic power of exhaled NO and all predictive equations failed to identify asthma, with AUC's ranging between 0.500 and 0.600, while in atopics, a small but significant improvement was seen (AUC ranged from 0.600 to 0.650).
Precision to distinguish between asthmatic and non-asthmatic children was improved when exhaled NO adjusted for spirometry was used, as shown in Figure 1 . The best ratios to identify asthma were exhaled NO/FEF 25%-75% (AUC = 0.652, P < .001) and exhaled NO/ FEF 75% (AUC = 0.646, P < .001). Moreover, when analysing atopic and non-atopic participants, results did not differ.
To The best cut-off values to identify uncontrolled asthma, and their respective specificity and sensibility are presented in Our study has a few limitations. First, the large number of asthmatic children in our study being treated with inhaled corticosteroids, a well-known modifier of exhaled NO levels 17, 18 and a high prevalence of allergic rhinitis, which is usually correlated with exhaled NO levels. Secondly, our evaluations were conducted during pollen season, contributing to high exhaled NO levels, even when asthma was not present, in pollen allergic patients. 19 Thirdly, the use of respiratory symptoms 
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The ability of exhaled NO to identify asthma in children has shown conflicting results; a cut-off value of 19 ppb has been suggested, with a sensitivity and specificity of 91% and 87%, respectively, for diagnosing mild asthma. 20 This was partially supported by a large real-life study of school aged children, where levels of exhaled NO above 15.8 ppb showed to be reliable to identify asthma. 21 Nonetheless, a different work suggested that exhaled NO was associated with atopy, but not asthma. between exhaled NO and FVC, FEV 1 , FEF 25%-75%, respectively , were suggested by the authors for asthma diagnose. 14 Our results differed, as we were not able to apply these indices. This is probably related to the studied populations; in Grzelewski et al, all children were recruited from an allergy department and had respiratory symptoms; our study was a population-based sample that represented school-age children. Therefore, our asthma prevalence was 11.2%, similar to the prevalence of Portuguese population, which was much lower than the prevalence of 59.7% found in Grzelewski study.
14 To our knowledge, no studies have yet evaluated the ability of spirometry-adjusted fraction of exhaled NO in assessing asthma control. Some studies have reported significant differences in exhaled NO levels between controlled and uncontrolled asthmatic children 23 and showed that children with levels below 20 ppb had significantly higher scores in Asthma Control Test (ACT) and child-ACT (C-ACT). 24 Additionally, exhaled NO levels correlated with poor asthma control status in inhaled corticosteroids (ICS) untreated cases. 25 Exhaled NO also proved to be a useful tool that distinguishes asthma severity and asthma control in children when FEV 1 fails to do it 26 as well as when its defined by a clinical evaluation. 27 Nevertheless, there is also evidence against the use of exhaled NO in the assessment of asthma control in children: it does not have enough discriminatory value in children under ICS treatment 10 and disagrees among common measures of asthma control such as the C-ACT. 28, 29 Spirometry-adjusted fraction of exhaled NO had a fair accuracy to distinguish between controlled and uncontrolled asthma. We found that 78% of the children had uncontrolled disease, defined by an increase of at least 12% of the FEV 1 after salbutamol or respiratory symptoms with exhaled NO level above than 35 ppb. This figure is fairly similar to other studies that reported about 75% uncontrolled asthma between 5 and 18 years of age. 10, 23, 30, 31 In our study, the ratio of exhaled NO/FEF 25%-75% arises as the best to assess asthma control, while the exhaled NO adjusted for A moderate-to-strong agreement between spirometry-adjusted fraction of exhaled NO cut-off levels and those from the ATS 3 was ob- 34 This finding suggests that the growth dependency in exhaled NO levels is probably due to growth-related increase in the airway area producing NO. Therefore, the spirometry adjustment could be regarded as a way to normalize this growth effect.
The use of the combined value of spirometry parameters and exhaled NO improves the diagnostic ability and better reflects disease control than either one alone. We also found that this exhaled NO/spirometry parameters index performs better in the non-atopic group to identify uncontrolled asthma. This may be due to a large number of false-positive results in the atopic population, which have higher values of exhaled NO, even when they achieve asthma control, as 73% of children with controlled asthma maintained increased NO levels. 23 We now can conclude that the use of spirometryadjusted fraction of exhaled NO improves asthma identification as well as asthma control assessment in school aged children and we suggest its use in epidemiological studies to assess children with asthma-like symptoms. T A B L E 2 Cut-off values and respective specificity and sensitivity values to identify uncontrolled asthma among children with asthma 34. Jacinto T, Malinovschi A, Janson C, Fonseca J, Alving K. Evolution of exhaled nitric oxide levels throughout development and aging of healthy humans. J Breath Res. 2015;9:036005.
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